Cyteir Leadership


Markus Renschler, MD
Markus Renschler, MDPresident & Chief Executive Officer
Barbara Wan, PhD
Barbara Wan, PhDVP, Research & Development Project Leadership
Jean-Marc Lapierre, PhD
Jean-Marc Lapierre, PhDVP, Chemistry
Susan Doleman
Susan DolemanVP, Clinical Operations
Tom O'Shea, PhD
Tom O'Shea, PhDSVP, Clinical Pharmacology & Preclinical Development
Andrew Gengos
Andrew GengosChief Business Officer
Paul Secrist, Ph.D.
Paul Secrist, Ph.D. Chief Scientific Officer
Judson Englert, M.D., Ph.D.
Judson Englert, M.D., Ph.D.VP, Clinical Research & Development

“It is with patients in the forefront of our minds that we work diligently to develop novel gain of function synthetic lethal therapies”

Melinda Anne Lynch Day, PhD – Principal Scientist, Cyteir Therapeutics, Inc.